Bicara Therapeutics Insider Trades
NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $4.80M
- Sales
- 43 · $7.85M
- Shares bought / sold
- 300.00K / 345.64K
- Net activity
- Net selling $3.1 million
Bicara Therapeutics insider activity
Over the last 12 months, Bicara Therapeutics insiders reported 78 transactions on SEC Form 4: 1 open-market purchase and 43 sales. Insiders bought $4.8 million and sold $7.9 million worth of stock, for net insider selling of $3.1 million. The largest seller was Cohlhepp Ryan, with $2.9 million in reported sales.
The most recent filing shows Cohlhepp Ryan (President, COO & Interim CEO) reporting a transaction in 17,500 shares at $3.79 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BCAX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BCAX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Cohlhepp RyanPresident, COO & Interim CEO | Sale | 3,442 | $80.66K | Form 4 |
| Sep 8, 2026 | Cohlhepp RyanPresident, COO & Interim CEO | Sale | 14,058 | $320.05K | Form 4 |
| Sep 8, 2026 | Cohlhepp RyanPresident, COO & Interim CEO | Option exercise | 17,500 | $66.32K | Form 4 |
| Aug 10, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 10,000 | $279.75K | Form 4 |
| Aug 10, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 10,000 | $37.90K | Form 4 |
| Aug 10, 2026 | Hyep IvanChief Financial Officer | Sale | 12,500 | $349.59K | Form 4 |
| Aug 10, 2026 | Hyep IvanChief Financial Officer | Option exercise | 12,500 | $47.37K | Form 4 |
| Aug 10, 2026 | Cohlhepp RyanPresident and COO | Sale | 18,750 | $524.53K | Form 4 |
| Aug 10, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 18,750 | $71.06K | Form 4 |
| Jul 10, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 28 | $831.04 | Form 4 |
| Jul 10, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 9,972 | $283.37K | Form 4 |
| Jul 10, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 10,000 | $37.90K | Form 4 |
| Jul 9, 2026 | Cohlhepp RyanPresident and COO | Sale | 536 | $15.54K | Form 4 |
| Jul 8, 2026 | Hyep IvanChief Financial Officer | Sale | 830 | $25.16K | Form 4 |
| Jul 8, 2026 | Hyep IvanChief Financial Officer | Sale | 4,413 | $131.62K | Form 4 |
| Jul 8, 2026 | Hyep IvanChief Financial Officer | Sale | 22,757 | $650.90K | Form 4 |
| Jul 8, 2026 | Hyep IvanChief Financial Officer | Option exercise | 12,500 | $47.37K | Form 4 |
| Jul 8, 2026 | Cohlhepp RyanPresident and COO | Sale | 1,075 | $32.63K | Form 4 |
| Jul 8, 2026 | Cohlhepp RyanPresident and COO | Sale | 4,306 | $128.30K | Form 4 |
| Jul 8, 2026 | Cohlhepp RyanPresident and COO | Sale | 22,833 | $656.65K | Form 4 |
| Jul 8, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 18,750 | $71.06K | Form 4 |
| May 21, 2026 | Hyep IvanChief Financial Officer | Sale | 9,200 | $187.88K | Form 4 |
| May 21, 2026 | Hyep IvanChief Financial Officer | Option exercise | 9,200 | $34.87K | Form 4 |
| May 18, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 2,978 | $60.60K | Form 4 |
| May 18, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 12,022 | $239.98K | Form 4 |
| May 18, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 15,000 | $56.85K | Form 4 |
| May 15, 2026 | Cohlhepp RyanPresident and COO | Sale | 4,500 | $91.31K | Form 4 |
| May 15, 2026 | Cohlhepp RyanPresident and COO | Sale | 8,000 | $162.34K | Form 4 |
| May 15, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 8,000 | $30.32K | Form 4 |
| Apr 27, 2026 | Raben DavidChief Medical Officer | Sale | 5,500 | $125.83K | Form 4 |
| Apr 27, 2026 | Raben DavidChief Medical Officer | Option exercise | 5,500 | $20.84K | Form 4 |
| Apr 21, 2026 | Hyep IvanChief Financial Officer | Sale | 9,200 | $211.61K | Form 4 |
| Apr 21, 2026 | Hyep IvanChief Financial Officer | Option exercise | 9,200 | $34.87K | Form 4 |
| Apr 20, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 15,000 | $354.15K | Form 4 |
| Apr 20, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 15,000 | $56.85K | Form 4 |
| Apr 16, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 7,080 | $38.61K | Form 4 |
| Apr 16, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 7,454 | $28.25K | Form 4 |
| Apr 16, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 8,226 | $36.50K | Form 4 |
| Apr 15, 2026 | Cohlhepp RyanPresident and COO | Sale | 4,500 | $103.53K | Form 4 |
| Apr 15, 2026 | Cohlhepp RyanPresident and COO | Sale | 8,000 | $184.06K | Form 4 |
| Apr 15, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 8,000 | $30.32K | Form 4 |
| Mar 25, 2026 | Raben DavidChief Medical Officer | Sale | 5,500 | $104.23K | Form 4 |
| Mar 25, 2026 | Raben DavidChief Medical Officer | Option exercise | 5,500 | $20.84K | Form 4 |
| Mar 23, 2026 | Hyep IvanChief Financial Officer | Sale | 9,200 | $170.35K | Form 4 |
| Mar 23, 2026 | Hyep IvanChief Financial Officer | Option exercise | 9,200 | $34.87K | Form 4 |
| Mar 20, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 1,596 | $30.25K | Form 4 |
| Mar 20, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 1,596 | $6.05K | Form 4 |
| Mar 19, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 6,905 | $129.70K | Form 4 |
| Mar 19, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 6,905 | $26.17K | Form 4 |
| Mar 18, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 6,499 | $122.41K | Form 4 |
| Mar 18, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 6,499 | $24.63K | Form 4 |
| Mar 16, 2026 | Cohlhepp RyanPresident and COO | Sale | 4,500 | $88.46K | Form 4 |
| Mar 16, 2026 | Cohlhepp RyanPresident and COO | Sale | 8,000 | $157.26K | Form 4 |
| Mar 16, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 8,000 | $30.32K | Form 4 |
| Mar 9, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 36,766 | $704.66K | Form 4 |
| Mar 9, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 36,766 | $139.34K | Form 4 |
| Mar 6, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 3,817 | $71.57K | Form 4 |
| Mar 6, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 3,817 | $14.47K | Form 4 |
| Mar 5, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 1,786 | $33.46K | Form 4 |
| Mar 5, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 1,786 | $6.77K | Form 4 |
| Mar 4, 2026 | Raben DavidChief Medical Officer | Sale | 16,300 | $301.92K | Form 4 |
| Mar 4, 2026 | Raben DavidChief Medical Officer | Option exercise | 16,300 | $61.77K | Form 4 |
| Mar 4, 2026 | Hyep IvanChief Financial Officer | Sale | 2,963 | $54.06K | Form 4 |
| Mar 4, 2026 | Hyep IvanChief Financial Officer | Option exercise | 2,963 | $11.23K | Form 4 |
| Mar 4, 2026 | Mazumdar ClaireChief Executive Officer | Sale | 2,631 | $49.29K | Form 4 |
| Mar 4, 2026 | Mazumdar ClaireChief Executive Officer | Option exercise | 2,631 | $9.97K | Form 4 |
| Mar 3, 2026 | Raben DavidChief Medical Officer | Sale | 200 | $3.69K | Form 4 |
| Mar 3, 2026 | Raben DavidChief Medical Officer | Option exercise | 200 | $757.96 | Form 4 |
| Mar 3, 2026 | Cohlhepp RyanPresident and COO | Sale | 4,500 | $81.73K | Form 4 |
| Mar 3, 2026 | Cohlhepp RyanPresident and COO | Sale | 12,892 | $234.16K | Form 4 |
| Mar 3, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 12,892 | $48.86K | Form 4 |
| Mar 3, 2026 | Hyep IvanChief Financial Officer | Sale | 13,555 | $246.91K | Form 4 |
| Mar 3, 2026 | Hyep IvanChief Financial Officer | Option exercise | 6,237 | $23.64K | Form 4 |
| Mar 3, 2026 | Hyep IvanChief Financial Officer | Option exercise | 7,318 | $27.73K | Form 4 |
| Feb 26, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 300,000 | $4.80M | Form 4 |
| Feb 25, 2026 | Cohlhepp RyanPresident and COO | Sale | 523 | $9.43K | Form 4 |
| Feb 25, 2026 | Cohlhepp RyanPresident and COO | Sale | 3,108 | $56.07K | Form 4 |
| Feb 25, 2026 | Cohlhepp RyanPresident and COO | Option exercise | 3,108 | $11.78K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4